These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32664834)

  • 1. Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling.
    Xu L; Sun L; Xie L; Mou S; Zhang D; Zhu J; Xu P
    Curr Med Chem; 2021; 28(3):514-524. PubMed ID: 32664834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: Implications for substance use, mood disorders and co-morbidities.
    Nunes EJ; Addy NA
    Neuropharmacology; 2023 Feb; 224():109336. PubMed ID: 36414149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of voltage-gated L-type Ca2+ channel isoforms for brain function.
    Striessnig J; Koschak A; Sinnegger-Brauns MJ; Hetzenauer A; Nguyen NK; Busquet P; Pelster G; Singewald N
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):903-9. PubMed ID: 17052224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.
    Kang S; Cooper G; Dunne SF; Luan CH; James Surmeier D; Silverman RB
    Bioorg Med Chem; 2013 Jul; 21(14):4365-73. PubMed ID: 23688558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of the 3D structure of the cardiac L-type voltage-gated calcium channel.
    Walsh CP; Davies A; Nieto-Rostro M; Dolphin AC; Kitmitto A
    Channels (Austin); 2009 Nov; 3(6):387-92. PubMed ID: 19875947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CACNA1C (Ca
    Harrison PJ; Husain SM; Lee H; Los Angeles A; Colbourne L; Mould A; Hall NAL; Haerty W; Tunbridge EM
    Neuropharmacology; 2022 Dec; 220():109262. PubMed ID: 36154842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-gated sodium channels: structures, functions, and molecular modeling.
    Xu L; Ding X; Wang T; Mou S; Sun H; Hou T
    Drug Discov Today; 2019 Jul; 24(7):1389-1397. PubMed ID: 31129313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-type calcium channels and psychiatric disorders: A brief review.
    Casamassima F; Hay AC; Benedetti A; Lattanzi L; Cassano GB; Perlis RH
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1373-90. PubMed ID: 20886543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated microgravity inhibits L-type calcium channel currents partially by the up-regulation of miR-103 in MC3T3-E1 osteoblasts.
    Sun Z; Cao X; Zhang Z; Hu Z; Zhang L; Wang H; Zhou H; Li D; Zhang S; Xie M
    Sci Rep; 2015 Jan; 5():8077. PubMed ID: 25627864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.
    Berger SM; Bartsch D
    Cell Tissue Res; 2014 Aug; 357(2):463-76. PubMed ID: 24996399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of Voltage gated Calcium channels.
    Mohan CG; Gandhi T
    Mini Rev Med Chem; 2008 Oct; 8(12):1285-90. PubMed ID: 18855741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives.
    Lanzetti S; Di Biase V
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential CaMKII regulation by voltage-gated calcium channels in the striatum.
    Pasek JG; Wang X; Colbran RJ
    Mol Cell Neurosci; 2015 Sep; 68():234-43. PubMed ID: 26255006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.
    Kang S; Cooper G; Dunne SF; Luan CH; Surmeier DJ; Silverman RB
    J Med Chem; 2013 Jun; 56(11):4786-97. PubMed ID: 23651412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of drug interaction with L-type Ca2+ channels.
    Mitterdorfer J; Grabner M; Kraus RL; Hering S; Prinz H; Glossmann H; Striessnig J
    J Bioenerg Biomembr; 1998 Aug; 30(4):319-34. PubMed ID: 9758329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.
    Mueller BH; Park Y; Daudt DR; Ma HY; Akopova I; Stankowska DL; Clark AF; Yorio T
    Exp Eye Res; 2013 Feb; 107():21-31. PubMed ID: 23183135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of an Imaging Probe to Monitor Real-Time Redistribution of L-type Voltage-Gated Calcium Channels in Astrocytic Glutamate Signaling.
    Tabatabaee MS; Kerkovius J; Menard F
    Mol Imaging Biol; 2021 Jun; 23(3):407-416. PubMed ID: 33432518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study.
    Xu L; Li D; Tao L; Yang Y; Li Y; Hou T
    Mol Biosyst; 2016 Feb; 12(2):379-90. PubMed ID: 26673131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDIMP, a novel cardiac Ca(2+) channel blocker with atrial selectivity.
    Santamaria-Herrera MA; Ríos-Pérez EB; de la Rosa JA; García-Castañeda M; Osornio-Garduño DS; Ramos-Mondragón R; Mancilla-Percino T; Avila G
    Eur J Pharmacol; 2016 Jun; 781():218-28. PubMed ID: 27089820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type voltage-gated calcium channels: understanding function through structure.
    Wang MC; Dolphin A; Kitmitto A
    FEBS Lett; 2004 Apr; 564(3):245-50. PubMed ID: 15111104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.